84 related articles for article (PubMed ID: 1493810)
1. Interleukin-1 is a motility factor for human breast carcinoma cells in vitro: additive effect with interleukin-6.
Verhasselt B; Van Damme J; van Larebeke N; Put W; Bracke M; De Potter C; Mareel M
Eur J Cell Biol; 1992 Dec; 59(2):449-57. PubMed ID: 1493810
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro.
Danforth DN; Sgagias MK
Cancer Res; 1993 Apr; 53(7):1538-45. PubMed ID: 8453620
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
Toi M; Bicknell R; Harris AL
Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
[TBL] [Abstract][Full Text] [Related]
4. IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells.
Chen L; Shulman LM; Revel M
J Biol Regul Homeost Agents; 1991; 5(4):125-36. PubMed ID: 1803860
[TBL] [Abstract][Full Text] [Related]
5. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
Elner VM; Burnstine MA; Strieter RM; Kunkel SL; Elner SG
Exp Eye Res; 1997 Dec; 65(6):781-9. PubMed ID: 9441701
[TBL] [Abstract][Full Text] [Related]
6. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines.
Morinaga Y; Suzuki H; Takatsuki F; Akiyama Y; Taniyama T; Matsushima K; Onozaki K
J Immunol; 1989 Dec; 143(11):3538-42. PubMed ID: 2584706
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
[TBL] [Abstract][Full Text] [Related]
10. Androgens block interleukin-1 beta-induced promatrilysin expression in prostate carcinoma cells.
Stratton MS; Greenstein B; Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2002 Sep; 53(1):1-8. PubMed ID: 12210475
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells.
Yamashita J; Ogawa M; Nomura K; Matsuo S; Inada K; Yamashita S; Nakashima Y; Saishoji T; Takano S; Fujita S
Cancer Res; 1993 Feb; 53(3):464-7. PubMed ID: 8425178
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha.
Tiggelman AM; Boers W; Linthorst C; Brand HS; Sala M; Chamuleau RA
J Hepatol; 1995 Sep; 23(3):295-306. PubMed ID: 8550994
[TBL] [Abstract][Full Text] [Related]
13. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
Belizario JE; Dinarello CA
Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
[TBL] [Abstract][Full Text] [Related]
15. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.
Sierra A; Price JE; García-Ramirez M; Méndez O; López L; Fabra A
Lab Invest; 1997 Oct; 77(4):357-68. PubMed ID: 9354770
[TBL] [Abstract][Full Text] [Related]
17. In vitro demonstration of breast cancer tumor cell sub-populations based on interleukin-1/tumor necrosis factor induction of interleukin-8 expression.
Pantschenko AG; Pushkar I; Miller LJ; Wang YP; Anderson K; Peled Z; Kurtzman SH; Kreutzer DL
Oncol Rep; 2003; 10(4):1011-7. PubMed ID: 12792762
[TBL] [Abstract][Full Text] [Related]
18. Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer.
Nozaki S; Sledge GW; Nakshatri H
Biochem Biophys Res Commun; 2000 Aug; 275(1):60-2. PubMed ID: 10944441
[TBL] [Abstract][Full Text] [Related]
19. Kupffer cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures.
Thornton AJ; Ham J; Kunkel SL
Hepatology; 1991 Dec; 14(6):1112-22. PubMed ID: 1660018
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells.
Zoja C; Wang JM; Bettoni S; Sironi M; Renzi D; Chiaffarino F; Abboud HE; Van Damme J; Mantovani A; Remuzzi G
Am J Pathol; 1991 Apr; 138(4):991-1003. PubMed ID: 2012180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
